ZNF75D: A Potential Drug Target and Biomarker (G7626)
ZNF75D: A Potential Drug Target and Biomarker
Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in gene regulation and have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. ZNF75D, a ZNF protein located on chromosome 16, is a potential drug target and biomarker for various diseases.
The ZNF75D gene encodes a protein composed of 75 amino acid residues, including a zinc finger domain and a non-coding region. The zinc finger domain is a conserved structural feature that consists of four amino acids (Arg/Glu/Asp/Gly) and is responsible for the protein's stability and functions as a zinc ion binding protein.
ZNF75D is expressed in various tissues and cells, including brain, spinal cord, heart, liver, and cancer cells. It has been shown to be involved in various cellular processes, including cell growth, apoptosis, angiogenesis, and inflammation. ZNF75D has also been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.
As a potential drug target, ZNF75D is of interest for its potential role in treating various diseases. For example, ZNF75D has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, targeting ZNF75D with small molecules or other therapeutic agents may be a promising approach to treating these diseases.
In addition to its potential as a drug target, ZNF75D has also been identified as a potential biomarker for various diseases. The ZNF75D protein is expressed in various tissues and cells and can be used as a protein biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.
One approach to using ZNF75D as a biomarker is to use it as a diagnostic biomarker for diseases. For example, the expression of ZNF75D has been shown to be elevated in various tissues and cells, including cancer cells, and can be used as a diagnostic biomarker for cancer.
Another approach to using ZNF75D as a biomarker is to use it as a target for small molecules or other therapeutic agents. The identification of small molecules that can interact with ZNF75D and modulate its function may be a promising approach to developing new treatments for various diseases.
In conclusion, ZNF75D is a promising drug target and biomarker for various diseases. The zinc finger domain and non-coding region of ZNF75D make it a promising target for small molecules or other therapeutic agents. Further research is needed to fully understand the role of ZNF75D in disease and to develop effective treatments.
Protein Name: Zinc Finger Protein 75D
Functions: May be involved in transcriptional regulation
More Common Targets
ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A
